CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on discovering new drug targets for treating anxiety disorders by investigating importin-dependent transport mechanisms. It aims to validate existing drugs that affect these pathways and screen for new compounds to develop effective anxiolytics.
Anxiety and stress-related conditions represent a significant health burden in modern society.
Anxiety disorders are currently treated with a variety of agents targeting synaptic mechanisms.
These agents either directly affect neurotransmitter receptor systems or modulate neurotransmitter levels or availability, but their long-term use is limited by problematic side effects and suboptimal efficacy.
The development of new anxiolytic drugs has been fraught with difficulty, hence there is a need fo…
WEIZMANN INSTITUTE OF SCIENCE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
